TABLE 5.
Comparison of HPV test results in samples collected in liquid-based medium and solid carrier devices in CVT participants, categorized by HPV cancer risk
| PC | FTA |
||||
|---|---|---|---|---|---|
| HPV16/18 | Carcinogenic HPV types other than HPV16/18 | Noncarcinogenic HPV | HPV− | Total no. (%) | |
| HPV16/18 | 21 | 2 | 0 | 0 | 23 (7.2) |
| Carcinogenic HPV typesa other than HPV16/18 | 1 | 54 | 4 | 2 | 61 (19.1) |
| Noncarcinogenic HPV | 1 | 6 | 52 | 3 | 62 (19.4) |
| HPV− | 3 | 11 | 19 | 140 | 173 (54.2) |
| Total (%)b | 26 (8.2) | 73 (22.9) | 75 (23.5) | 145 (45.5) | 319 |
a
The carcinogenic HPV types included HPV16, -18, -31, -33, -35, -39, -45, -51, -52, -56, -58, -66, and -68/73.
b
Overall agreement was 0.84, the agreement between positives in both media was 0.71, and the weighted kappa (95% CI) was 0.79 (0.73 to 0.85).